HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 178 filers reported holding HAEMONETICS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,858,669 | +5.7% | 199,360 | +0.4% | 0.01% | +8.3% |
| Q2 2023 | $16,901,653 | -1.5% | 198,516 | -4.3% | 0.01% | 0.0% |
| Q1 2023 | $17,165,991 | +4.5% | 207,444 | -0.7% | 0.01% | 0.0% |
| Q4 2022 | $16,422,514 | +4.0% | 208,805 | -2.1% | 0.01% | -7.7% |
| Q3 2022 | $15,796,000 | +2.3% | 213,371 | -9.9% | 0.01% | +18.2% |
| Q2 2022 | $15,441,000 | +34.0% | 236,898 | +29.9% | 0.01% | +57.1% |
| Q1 2022 | $11,526,000 | +18.4% | 182,315 | -0.7% | 0.01% | +16.7% |
| Q4 2021 | $9,738,000 | -23.7% | 183,597 | +1.6% | 0.01% | -25.0% |
| Q3 2021 | $12,762,000 | +6.1% | 180,790 | +0.2% | 0.01% | 0.0% |
| Q2 2021 | $12,027,000 | -71.5% | 180,471 | -52.6% | 0.01% | -73.3% |
| Q1 2021 | $42,245,000 | +132.1% | 380,548 | +148.3% | 0.03% | +130.8% |
| Q4 2020 | $18,200,000 | +35.6% | 153,263 | -0.3% | 0.01% | +18.2% |
| Q3 2020 | $13,418,000 | -5.6% | 153,784 | -3.1% | 0.01% | -15.4% |
| Q2 2020 | $14,220,000 | -9.6% | 158,777 | +0.6% | 0.01% | -23.5% |
| Q1 2020 | $15,731,000 | -38.7% | 157,850 | -29.3% | 0.02% | -19.0% |
| Q4 2019 | $25,657,000 | -9.5% | 223,293 | -0.7% | 0.02% | -16.0% |
| Q3 2019 | $28,364,000 | +2.8% | 224,857 | -1.9% | 0.02% | 0.0% |
| Q2 2019 | $27,594,000 | +33.1% | 229,304 | -3.2% | 0.02% | +31.6% |
| Q1 2019 | $20,729,000 | -12.9% | 236,962 | -0.4% | 0.02% | -24.0% |
| Q4 2018 | $23,805,000 | -20.2% | 237,931 | -8.6% | 0.02% | -3.8% |
| Q3 2018 | $29,822,000 | +29.8% | 260,278 | +1.6% | 0.03% | +23.8% |
| Q2 2018 | $22,972,000 | -29.7% | 256,154 | -42.6% | 0.02% | -32.3% |
| Q1 2018 | $32,662,000 | +30.7% | 446,448 | +3.7% | 0.03% | +34.8% |
| Q4 2017 | $24,997,000 | +29.3% | 430,375 | -0.1% | 0.02% | +21.1% |
| Q3 2017 | $19,340,000 | +12.7% | 431,013 | -0.8% | 0.02% | +11.8% |
| Q2 2017 | $17,154,000 | +4.2% | 434,390 | +7.1% | 0.02% | -15.0% |
| Q1 2017 | $16,455,000 | +4.9% | 405,578 | +3.9% | 0.02% | 0.0% |
| Q4 2016 | $15,687,000 | +14.1% | 390,209 | +2.7% | 0.02% | +11.1% |
| Q3 2016 | $13,754,000 | +32.0% | 379,833 | +5.7% | 0.02% | +20.0% |
| Q2 2016 | $10,422,000 | -16.9% | 359,520 | +0.3% | 0.02% | -16.7% |
| Q1 2016 | $12,542,000 | +13.1% | 358,559 | +4.2% | 0.02% | +12.5% |
| Q4 2015 | $11,094,000 | +4.9% | 344,105 | +5.1% | 0.02% | -5.9% |
| Q3 2015 | $10,580,000 | -21.0% | 327,337 | +1.1% | 0.02% | -15.0% |
| Q2 2015 | $13,388,000 | -9.4% | 323,710 | -1.6% | 0.02% | -9.1% |
| Q1 2015 | $14,770,000 | +23.4% | 328,814 | +2.8% | 0.02% | +15.8% |
| Q4 2014 | $11,970,000 | +6.8% | 319,879 | -0.4% | 0.02% | 0.0% |
| Q3 2014 | $11,212,000 | -3.3% | 321,070 | -2.3% | 0.02% | 0.0% |
| Q2 2014 | $11,590,000 | +7.6% | 328,533 | -0.6% | 0.02% | 0.0% |
| Q1 2014 | $10,771,000 | -19.3% | 330,479 | +4.3% | 0.02% | -24.0% |
| Q4 2013 | $13,346,000 | +12.6% | 316,783 | +6.6% | 0.02% | +4.2% |
| Q3 2013 | $11,856,000 | -0.2% | 297,283 | +3.4% | 0.02% | -7.7% |
| Q2 2013 | $11,884,000 | – | 287,396 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |